Myeloperoxidase (MPO) is a biomarker of inflammation and oxidative stress produced by neutrophils, monocytes, and endothelial cells1. MPO levels increase in patients with heart failure. Increased MPO is associated with prognosis and left ventricular function in these patients. Heart-type fatty acid-binding protein (H-FABP) is a low molecular weight (15 kD) cytoplasmic protein, whose role is intracellular transportation of free fatty acid in the cardiomyocyte.H-FABP is widely used to evaluate ongoing myocardial damage. Aim: The aim of the present study was to investigate the relationship between MPO and myocardial damage. Methods: We studied 42 consecutive patients with chronic heart failure. Serum H-FABP and MPO levels were measured by ELISA kits. Routine biochemical and clinical parameters were recorded. Echocardiographic examinations were performed in all patients.
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Diyarbakır Education and Research Hospital, Diyarbakir, 2 Hacettepe University Cardiology Department, Ankara, 3 Dicle University Cardiology Department, Diyarbakir Aim: Heart failure is a chronic progression characterized by neuroendocrine system maladaptation. This chronic progressive situation reflects an increase in sympathetic activity and peripheral vascular resistance and a decrease in baroreceptor sensitivity, and could be the cause of changes in the diurnal rhythm of blood pressure. However, some trials show that the circadian rhythm of blood pressure in patients with severe systolic heart failure does not differ from that of control groups. In contrast, trials generally show that nondipper and reverse dipper patients more frequently experience severe heart failure. No trials have examined the effects of heart failure etiology for this situation. Our purpose is to determine the circadian rhythm differences between ischemic and nonischemic cardiomyopathy patients. Materıal-Method: Our study included 66 patients: 22 with ischemic cardiomyopathy, 22 with nonischemic cardiomyopathy, and 22 as a control group. The ejection fraction was under 40% with sinus rhythm, and the left heart was enlarged, with no biventricular pace implantation, no severe heart valve disease; no patient was receiving dialysis. All patients underwent hemograms and routine laboratory tests and their BMIs and GFRs were calculated. Echocardiographic tests were conducted on all patients and each patient took a 24 hour ambulatory blood pressure device and prepared for the study.
Results: The ischemic cardiomyopathy group (21M, 1F) had a statistically significant higher male patient ratio than the nonischemic cardiomyopathy group (14M, 8F) and the control group (13M, 9F). A statistically high statin use also occurred in the ischemic cardiomyopathy group compared to the nonischemic cardiomyopathy group. No significant differences existed between the ischemic and nonischemic cardiomyopathy patients for ejection fraction, age, DM, HT, glomerular filtration rate, body mass index, hemogram, and routine laboratory tests. In control group dippers, in nonischemic cardiomyopathy group nondippers, and in ischemic cardiomyopathy group, the number of reverse dippers was statistically high (p<0.001).
Conclusıon: This study showed that the diurnal rhythm of blood pressure changes in severe systolic heart failure. In the nonischemic cardiomyopathy group, 54% of the patients were nondippers and 27.3% were reverse dippers. In the ischemic cardiomyopathy group, 63.6% of the patients were reverse dippers and 27.3% were nondippers. When we combined the findings of our study, the ischemic cardiomyopathy group had a higher future mortality and hospitalization than the nonischemic cardiomyopathy group because the number of reverse dippers was significantly higher in this group. This emphasizes the importance of ambulatory blood pressure monitoring and evaluation of the nondipper situation in the prognosis of congestive heart failure in these patients. Ambulatory blood pressure monitoring has an important role in determining the drug taking hours.
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Spironolactone Prevents the Heart Againts Anthracycline Cardiotoxicity Background: The most important adverse event of anthracyclines is cardiotoxicity and can limit the use of them. Spironolactone is an aldosterone antagonist and has antifibrotic and antioxidant effects. In the present study, we aimed to investigate the effects of spironolactone in the prevention of the cardiotoxic effects of the anthracycline. Materıals-Methods: A total of 83 female patients who diagnosed with breast cancer and planned anthracycline including chemotherapy regimen were enrolled in to the study. Study population were randomized as spironolactone and control group. Twenty five mg/day spironolactone was administrated to the patients in spironolactone group. Results: LVEF decreased from 67.0AE6.1 to 65.7AE7.4 (p¼0.094) in the spironolactone group, while from 67.7AE6.3 to 53.6AE6.8 in control group (p<0.001). Diastolic functional class was prevented in spironolactone group (p¼0.247). In the control group, however, diastolic functional class was deteriorated (p<0.001). Mitral inflow E wave/lateral wall e' wave ratio which is one of the most important sign of the diastolic functions was significantly increased in the control group while prevented in the spironolactone group. Conclusıons: Prophylactic administration of spironolactone 25 mg/day prevents the left ventricular systolic and diastolic functions in patients who administrated anthracyclines.
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Tenascin-C as Predictor of Left Ventricular Remodeling and Mortality in Patients with Dilated Cardiomyopathy
Bahadır Şarlı 1 , Topsakal Ramazan 1 , Esma G Kaya 2 , Mahmut Akpek 1 , Yat Yin Lam 3 , Mehmet G Kaya 1 Methods: Sixty-six patients with DCM were followed-up for 12 months after initiation of medical treatment including carvedilol, ramipril (candesartan if ramipril was not tolerated), spironolactone and furosemide. Tenascin-C and NT pro-BNP measurements and transthoracic echocardiography was performed at baseline and at 12 months. Results: At 12 months, a significant improvement in NYHA class (2.57AE0.6 vs. 1.87AE0.5, p<0.0001), left ventricular end-diastolic volume (217AE47 vs. 203 AE 48, p<0.0001), left ventricular ejection fraction (29.1AE5.5 vs. 30.9AE3.8, p<0.0001), NT pro-BNP (2019AE558 vs. 1462AE805, p<0.0001) and Tenascin-C (76AE19 vs. 48AE28, p<0.0001) values were observed, when compared with baseline. Importantly, decrease in Tenascin-C values were correlated with increase in LVEF. Tenascin-C (odds ratio (OR): 1.896, <95% confidence interval (CI) 1.543-2.670; p¼0.02), DM (OR: 2.456, <95% Cl 1.987-3.234; p¼0.01) and HT (OR: 2.106, <95% Cl 1.876-2.897; p¼0.03) were independent predictors of mortality in patients with DCM. Conclusıon: Reverse ventricular remodeling obtained with carvedilol, ramipril/ candesartan and spironolactone is associated with decreases in LVEDV, LVESV, Tenascin-C levels and NT pro-BNP levels. Consequently, Tenascin-C may be used to evaluate reverse remodeling in patients with DCM.
PP-060 -21, miR-4278, miR-650, miR-744star, miR-516-5p, miR-1292, miR-182, miR-1228, miR-595, miR-663b, miR-1296, miR-1825, miR-299-3p, miR-662 miR-122-star, miR-3148, miR-518e-star, miR-2054 as up regulated, and serum miR-129-3p, miR-3155, miR-3175, miR-583, miR-568, miR-30d, miR-200a-star, miR-1979, miR-371-3p, miR-155-star, miR-502-5p as down regulated in CHF patients with a significant increase of >1.2 fold (p<0.05) (Figure) . There was no association between these miRNAs and important clinical prognostic parameters such as NYHA class (p>0.05), pro-BNP (p>0.05) and high sensitive C-reactive protein (hs-CRP) (p>0.05).
Conclusıon: The present study indicated that patients with heart failure exhibit different serum miRNA profile compared to healthy controls.
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Assessment Aim: Heart failure is a cardiovascular disease that is caused by impaired left ventricular systolic and diastolic function. Ischemic and non-ischemic cardiomyopathies are the most common cause of heart failure. Its mortality is high despite to the new treatment regimens. Along with dilatation left ventricul, right ventricular changes, particularly structural and functional, occurs in the advanced heart failure. Assessment of the right ventricular function is very important as it has prognostic significance in mortality and morbidity. Although right ventricle is often neglected due to complexity in the assessment of function and structure, provides valuable information on the current practice. Impaired parameters used in the assessment of right ventricular
